Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
Folia Med (Plovdiv)
; 66(2): 196-202, 2024 Apr 30.
Article
em En
| MEDLINE
| ID: mdl-38690814
ABSTRACT
INTRODUCTION:
Osteosarcoma (OS) and Ewing sarcoma (ES) represent the pediatric population's most common malignant bone tumors. 18-Fluorodeoxyglucose positron emission tomography has been shown to be effective in both the diagnostic and staging phases of cancer treatment. In recent years, some studies have also explored the possibility that FDG-PET could have a prognostic role.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sarcoma de Ewing
/
Neoplasias Ósseas
/
Osteossarcoma
/
Compostos Radiofarmacêuticos
/
Fluordesoxiglucose F18
/
Tomografia por Emissão de Pósitrons
Limite:
Humans
Idioma:
En
Revista:
Folia Med (Plovdiv)
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Itália